A detailed history of Wells Fargo & Company transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 76,489 shares of LXRX stock, worth $65,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,489
Previous 45,601 67.74%
Holding current value
$65,780
Previous $76,000 57.89%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.51 - $2.39 $46,640 - $73,822
30,888 Added 67.74%
76,489 $120,000
Q2 2024

Aug 13, 2024

BUY
$1.54 - $2.28 $22,462 - $33,256
14,586 Added 47.03%
45,601 $76,000
Q1 2024

May 10, 2024

BUY
$1.3 - $3.58 $5,564 - $15,322
4,280 Added 16.01%
31,015 $74,000
Q4 2023

Feb 09, 2024

BUY
$1.0 - $1.53 $5,571 - $8,523
5,571 Added 26.32%
26,735 $40,000
Q3 2023

Nov 13, 2023

SELL
$1.06 - $2.33 $16,600 - $36,490
-15,661 Reduced 42.53%
21,164 $23,000
Q2 2023

Aug 15, 2023

BUY
$2.15 - $3.49 $46,143 - $74,902
21,462 Added 139.7%
36,825 $84,000
Q1 2023

May 12, 2023

BUY
$1.99 - $2.68 $30,572 - $41,172
15,363 New
15,363 $37,000
Q3 2022

Nov 14, 2022

SELL
$1.94 - $3.43 $1,098 - $1,941
-566 Reduced 42.65%
761 $2,000
Q2 2022

Aug 12, 2022

SELL
$1.31 - $2.69 $233,998 - $480,501
-178,625 Reduced 99.26%
1,327 $2,000
Q1 2022

May 16, 2022

SELL
$1.95 - $3.89 $609,919 - $1.22 Million
-312,779 Reduced 63.48%
179,952 $376,000
Q4 2021

Feb 14, 2022

SELL
$3.81 - $6.16 $229,483 - $371,029
-60,232 Reduced 10.89%
492,731 $1.94 Million
Q3 2021

Nov 15, 2021

BUY
$3.38 - $5.35 $877,295 - $1.39 Million
259,555 Added 88.46%
552,963 $2.66 Million
Q2 2021

Aug 16, 2021

BUY
$4.12 - $5.87 $1.01 Million - $1.44 Million
244,808 Added 503.72%
293,408 $1.35 Million
Q1 2021

May 13, 2021

SELL
$3.45 - $9.09 $30,660 - $80,782
-8,887 Reduced 15.46%
48,600 $285,000
Q4 2020

Feb 09, 2021

SELL
$1.05 - $3.67 $97,236 - $339,864
-92,606 Reduced 61.7%
57,487 $197,000
Q3 2020

Nov 05, 2020

BUY
$1.44 - $2.1 $59,653 - $86,994
41,426 Added 38.12%
150,093 $216,000
Q2 2020

Aug 13, 2020

BUY
$1.75 - $2.3 $360 - $473
206 Added 0.19%
108,667 $217,000
Q1 2020

May 14, 2020

BUY
$1.8 - $4.28 $195,229 - $464,213
108,461 New
108,461 $212,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $162M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.